Cervus elaphus chromosome 28, mCerEla1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU343105.1.\nAssembly name: mCerEla1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/07/07. The original whole-genome shotgun project has the\naccession CAJVBL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus elaphus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
protein tyrosine phosphatase 4A1, transcript variant X1
protein tyrosine phosphatase 4A1, transcript variant X3
protein tyrosine phosphatase 4A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
PHD finger protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 13 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PHD finger protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 13 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PHD finger protein 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 13 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PHD finger protein 3, transcript variant X9
PHD finger protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 13 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PHD finger protein 3, transcript variant X8
PHD finger protein 3, transcript variant X1
PHD finger protein 3, transcript variant X2
PHD finger protein 3, transcript variant X3
PHD finger protein 3, transcript variant X4
PHD finger protein 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; substituted 6 bases at 6 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein eyes shut homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 ESTs, and 64% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
eukaryotic translation initiation factor 3 subunit E-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 17 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
adhesion G protein-coupled receptor B3, transcript variant X2
adhesion G protein-coupled receptor B3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
lysosomal cobalamin transport escort protein LMBD1
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
family with sequence similarity 135 member A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
succinate dehydrogenase complex assembly factor 4, transcript variant X1
succinate dehydrogenase assembly factor 4, mitochondrial isoform X1
succinate dehydrogenase complex assembly factor 4, transcript variant X2
succinate dehydrogenase assembly factor 4, mitochondrial isoform X2
stromal membrane-associated protein 1 isoform X1
stromal membrane-associated protein 1 isoform X3
stromal membrane-associated protein 1 isoform X2
stromal membrane-associated protein 1 isoform X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2
cytochrome c oxidase subunit 5A, mitochondrial-like
opioid growth factor receptor like 1, transcript variant X1
opioid growth factor receptor like 1, transcript variant X2
opioid growth factor receptor-like protein 1 isoform X1
opioid growth factor receptor-like protein 1 isoform X2
opioid growth factor receptor like 1, transcript variant X3
opioid growth factor receptor like 1, transcript variant X4
opioid growth factor receptor-like protein 1 isoform X3
opioid growth factor receptor-like protein 1 isoform X4
regulating synaptic membrane exocytosis 1, transcript variant X1
regulating synaptic membrane exocytosis 1, transcript variant X2
regulating synaptic membrane exocytosis 1, transcript variant X3
regulating synaptic membrane exocytosis 1, transcript variant X18
regulating synaptic membrane exocytosis 1, transcript variant X6
regulating synaptic membrane exocytosis 1, transcript variant X20
regulating synaptic membrane exocytosis 1, transcript variant X9
regulating synaptic membrane exocytosis 1, transcript variant X22
regulating synaptic membrane exocytosis 1, transcript variant X5
regulating synaptic membrane exocytosis 1, transcript variant X13
regulating synaptic membrane exocytosis 1, transcript variant X25
regulating synaptic membrane exocytosis 1, transcript variant X15
regulating synaptic membrane exocytosis 1, transcript variant X27
regulating synaptic membrane exocytosis 1, transcript variant X4
regulating synaptic membrane exocytosis 1, transcript variant X19
regulating synaptic membrane exocytosis 1, transcript variant X7
regulating synaptic membrane exocytosis 1, transcript variant X8
regulating synaptic membrane exocytosis 1, transcript variant X21
regulating synaptic membrane exocytosis 1, transcript variant X10
regulating synaptic membrane exocytosis 1, transcript variant X12
regulating synaptic membrane exocytosis 1, transcript variant X23
regulating synaptic membrane exocytosis 1, transcript variant X11
regulating synaptic membrane exocytosis 1, transcript variant X24
regulating synaptic membrane exocytosis 1, transcript variant X14
regulating synaptic membrane exocytosis 1, transcript variant X26
regulating synaptic membrane exocytosis 1, transcript variant X16
regulating synaptic membrane exocytosis 1, transcript variant X17
regulating synaptic membrane exocytosis 1, transcript variant X28
regulating synaptic membrane exocytosis protein 1 isoform X1
regulating synaptic membrane exocytosis protein 1 isoform X2
regulating synaptic membrane exocytosis protein 1 isoform X3
regulating synaptic membrane exocytosis protein 1 isoform X18
regulating synaptic membrane exocytosis protein 1 isoform X6
regulating synaptic membrane exocytosis protein 1 isoform X20
regulating synaptic membrane exocytosis protein 1 isoform X9
regulating synaptic membrane exocytosis protein 1 isoform X22
regulating synaptic membrane exocytosis protein 1 isoform X5
regulating synaptic membrane exocytosis protein 1 isoform X13
regulating synaptic membrane exocytosis protein 1 isoform X25
regulating synaptic membrane exocytosis protein 1 isoform X15
regulating synaptic membrane exocytosis protein 1 isoform X27
regulating synaptic membrane exocytosis protein 1 isoform X4
regulating synaptic membrane exocytosis protein 1 isoform X19
regulating synaptic membrane exocytosis protein 1 isoform X7
regulating synaptic membrane exocytosis protein 1 isoform X8
regulating synaptic membrane exocytosis protein 1 isoform X21
regulating synaptic membrane exocytosis protein 1 isoform X10
regulating synaptic membrane exocytosis protein 1 isoform X12
regulating synaptic membrane exocytosis protein 1 isoform X23
regulating synaptic membrane exocytosis protein 1 isoform X11
regulating synaptic membrane exocytosis protein 1 isoform X24
regulating synaptic membrane exocytosis protein 1 isoform X14
regulating synaptic membrane exocytosis protein 1 isoform X26
regulating synaptic membrane exocytosis protein 1 isoform X16
regulating synaptic membrane exocytosis protein 1 isoform X17
regulating synaptic membrane exocytosis protein 1 isoform X28
regulating synaptic membrane exocytosis 1, transcript variant X29
regulating synaptic membrane exocytosis 1, transcript variant X40
regulating synaptic membrane exocytosis 1, transcript variant X31
regulating synaptic membrane exocytosis 1, transcript variant X42
regulating synaptic membrane exocytosis 1, transcript variant X33
regulating synaptic membrane exocytosis 1, transcript variant X44
regulating synaptic membrane exocytosis 1, transcript variant X46
regulating synaptic membrane exocytosis 1, transcript variant X37
regulating synaptic membrane exocytosis 1, transcript variant X48
regulating synaptic membrane exocytosis 1, transcript variant X30
regulating synaptic membrane exocytosis 1, transcript variant X41
regulating synaptic membrane exocytosis 1, transcript variant X32
regulating synaptic membrane exocytosis 1, transcript variant X43
regulating synaptic membrane exocytosis 1, transcript variant X34
regulating synaptic membrane exocytosis 1, transcript variant X35
regulating synaptic membrane exocytosis 1, transcript variant X45
regulating synaptic membrane exocytosis 1, transcript variant X36
regulating synaptic membrane exocytosis 1, transcript variant X47
regulating synaptic membrane exocytosis 1, transcript variant X38
regulating synaptic membrane exocytosis 1, transcript variant X39
regulating synaptic membrane exocytosis 1, transcript variant X49
regulating synaptic membrane exocytosis protein 1 isoform X29
regulating synaptic membrane exocytosis protein 1 isoform X40
regulating synaptic membrane exocytosis protein 1 isoform X31
regulating synaptic membrane exocytosis protein 1 isoform X42
regulating synaptic membrane exocytosis protein 1 isoform X33
regulating synaptic membrane exocytosis protein 1 isoform X44
regulating synaptic membrane exocytosis protein 1 isoform X46
regulating synaptic membrane exocytosis protein 1 isoform X37
regulating synaptic membrane exocytosis protein 1 isoform X48
regulating synaptic membrane exocytosis protein 1 isoform X30
regulating synaptic membrane exocytosis protein 1 isoform X41
regulating synaptic membrane exocytosis protein 1 isoform X32
regulating synaptic membrane exocytosis protein 1 isoform X43
regulating synaptic membrane exocytosis protein 1 isoform X34
regulating synaptic membrane exocytosis protein 1 isoform X35
regulating synaptic membrane exocytosis protein 1 isoform X45
regulating synaptic membrane exocytosis protein 1 isoform X36
regulating synaptic membrane exocytosis protein 1 isoform X47
regulating synaptic membrane exocytosis protein 1 isoform X38
regulating synaptic membrane exocytosis protein 1 isoform X39
regulating synaptic membrane exocytosis protein 1 isoform X49
regulating synaptic membrane exocytosis 1, transcript variant X50
regulating synaptic membrane exocytosis protein 1 isoform X50
potassium voltage-gated channel subfamily Q member 5, transcript variant X1
potassium voltage-gated channel subfamily Q member 5, transcript variant X2
potassium voltage-gated channel subfamily Q member 5, transcript variant X4
potassium voltage-gated channel subfamily Q member 5, transcript variant X3
potassium voltage-gated channel subfamily Q member 5, transcript variant X5
potassium voltage-gated channel subfamily KQT member 5 isoform X1
potassium voltage-gated channel subfamily KQT member 5 isoform X2
potassium voltage-gated channel subfamily KQT member 5 isoform X4
potassium voltage-gated channel subfamily KQT member 5 isoform X3
potassium voltage-gated channel subfamily KQT member 5 isoform X5
potassium voltage-gated channel subfamily Q member 5, transcript variant X6
potassium voltage-gated channel subfamily KQT member 5 isoform X6
KH domain containing 3 like, subcortical maternal complex member
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
probable ATP-dependent RNA helicase DDX43
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122685434, transcript variant X3
uncharacterized LOC122685434, transcript variant X2
uncharacterized LOC122685434, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122685434 isoform X2
uncharacterized protein LOC122685434 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
striated muscle preferentially expressed protein kinase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
skin secretory protein xP2-like, transcript variant X4
skin secretory protein xP2-like, transcript variant X1
skin secretory protein xP2-like, transcript variant X5
skin secretory protein xP2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
skin secretory protein xP2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
skin secretory protein xP2-like, transcript variant X6
proline-rich proteoglycan 2-like, transcript variant X4
proline-rich proteoglycan 2-like, transcript variant X1
proline-rich proteoglycan 2-like, transcript variant X3
proline-rich proteoglycan 2-like, transcript variant X2
uncharacterized protein LOC122685433 isoform X1
uncharacterized protein LOC122685433 isoform X3
proline-rich proteoglycan 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor-associated protein-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 57 ESTs, 17 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial tRNA translation optimization 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitochondrial tRNA translation optimization 1, transcript variant X1
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
eukaryotic translation elongation factor 1 alpha 1
solute carrier family 17 member 5, transcript variant X5
solute carrier family 17 member 5, transcript variant X6
solute carrier family 17 member 5, transcript variant X2
solute carrier family 17 member 5, transcript variant X4
solute carrier family 17 member 5, transcript variant X1
solute carrier family 17 member 5, transcript variant X3
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1-like
uncharacterized LOC122685328, transcript variant X1
uncharacterized LOC122685328, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
collagen type XII alpha 1 chain, transcript variant X3
collagen type XII alpha 1 chain, transcript variant X1
collagen type XII alpha 1 chain, transcript variant X2
cytochrome c oxidase subunit 7A2, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cell cycle control protein 50A
filamin A interacting protein 1, transcript variant X2
filamin A interacting protein 1, transcript variant X4
filamin-A-interacting protein 1 isoform X2
filamin A interacting protein 1, transcript variant X1
filamin A interacting protein 1, transcript variant X3
filamin-A-interacting protein 1 isoform X1
SUMO specific peptidase 6, transcript variant X1
SUMO specific peptidase 6, transcript variant X2
SUMO specific peptidase 6, transcript variant X3
SUMO specific peptidase 6, transcript variant X5
SUMO specific peptidase 6, transcript variant X7
SUMO specific peptidase 6, transcript variant X8
SUMO specific peptidase 6, transcript variant X4
SUMO specific peptidase 6, transcript variant X6
SUMO specific peptidase 6, transcript variant X9
protein transport protein Sec61 subunit gamma-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
interphotoreceptor matrix proteoglycan 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interphotoreceptor matrix proteoglycan 1
peptidyl-prolyl cis-trans isomerase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
meiotic double-stranded break formation protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
meiotic double-stranded break formation protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eukaryotic translation initiation factor 3 subunit C-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 576 ESTs, 30 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
interleukin 1 receptor associated kinase 1 binding protein 1
interleukin-1 receptor-associated kinase 1-binding protein 1
pleckstrin homology domain interacting protein, transcript variant X2
pleckstrin homology domain interacting protein, transcript variant X1
high mobility group nucleosomal binding domain 3, transcript variant X2
high mobility group nucleosomal binding domain 3, transcript variant X4
high mobility group nucleosomal binding domain 3, transcript variant X1
high mobility group nucleosome-binding domain-containing protein 3 isoform X4
high mobility group nucleosome-binding domain-containing protein 3 isoform X2
high mobility group nucleosome-binding domain-containing protein 3 isoform X1
high mobility group nucleosomal binding domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
high mobility group nucleosome-binding domain-containing protein 3 isoform X3
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
SH3 domain binding glutamate rich protein like 2
SH3 domain-binding glutamic acid-rich-like protein 2
elongation of very long chain fatty acids protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TTK protein kinase, transcript variant X3
TTK protein kinase, transcript variant X2
TTK protein kinase, transcript variant X7
TTK protein kinase, transcript variant X8
TTK protein kinase, transcript variant X1
TTK protein kinase, transcript variant X5
TTK protein kinase, transcript variant X6
TTK protein kinase, transcript variant X4
dual specificity protein kinase TTK isoform X1
dual specificity protein kinase TTK isoform X2
dual specificity protein kinase TTK isoform X4
dual specificity protein kinase TTK isoform X5
dual specificity protein kinase TTK isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00568
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC122685248
branched chain keto acid dehydrogenase E1 subunit beta
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial
uncharacterized LOC122685523, transcript variant X2
uncharacterized LOC122685523, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
terminal nucleotidyltransferase 5A, transcript variant X2
terminal nucleotidyltransferase 5A, transcript variant X1
terminal nucleotidyltransferase 5A isoform X2
terminal nucleotidyltransferase 5A isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
inhibitor of Bruton tyrosine kinase, transcript variant X2
inhibitor of Bruton tyrosine kinase, transcript variant X3
inhibitor of Bruton tyrosine kinase, transcript variant X1
inhibitor of Bruton tyrosine kinase isoform X2
inhibitor of Bruton tyrosine kinase isoform X3
inhibitor of Bruton tyrosine kinase isoform X1
uncharacterized LOC122685281, transcript variant X2
uncharacterized LOC122685281, transcript variant X4
uncharacterized protein LOC122685281 isoform X2
uncharacterized LOC122685281, transcript variant X3
uncharacterized LOC122685281, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC122685281 isoform X1
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ubiquitin protein ligase E3D, transcript variant X6
ubiquitin protein ligase E3D, transcript variant X1
ubiquitin protein ligase E3D, transcript variant X3
ubiquitin protein ligase E3D, transcript variant X5
ubiquitin protein ligase E3D, transcript variant X2
ubiquitin protein ligase E3D, transcript variant X4
E3 ubiquitin-protein ligase E3D isoform X3
E3 ubiquitin-protein ligase E3D isoform X5
E3 ubiquitin-protein ligase E3D isoform X6
E3 ubiquitin-protein ligase E3D isoform X1
E3 ubiquitin-protein ligase E3D isoform X2
E3 ubiquitin-protein ligase E3D isoform X4
DOP1 leucine zipper like protein A, transcript variant X1
DOP1 leucine zipper like protein A, transcript variant X5
DOP1 leucine zipper like protein A, transcript variant X4
DOP1 leucine zipper like protein A, transcript variant X6
DOP1 leucine zipper like protein A, transcript variant X2
DOP1 leucine zipper like protein A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
serine protease 35, transcript variant X2
serine protease 35, transcript variant X1
serine protease 35, transcript variant X3
synaptosome associated protein 91, transcript variant X2
synaptosome associated protein 91, transcript variant X15
synaptosome associated protein 91, transcript variant X13
synaptosome associated protein 91, transcript variant X9
synaptosome associated protein 91, transcript variant X8
synaptosome associated protein 91, transcript variant X5
synaptosome associated protein 91, transcript variant X7
synaptosome associated protein 91, transcript variant X11
synaptosome associated protein 91, transcript variant X6
synaptosome associated protein 91, transcript variant X10
synaptosome associated protein 91, transcript variant X1
synaptosome associated protein 91, transcript variant X3
synaptosome associated protein 91, transcript variant X4
synaptosome associated protein 91, transcript variant X14
synaptosome associated protein 91, transcript variant X12
clathrin coat assembly protein AP180 isoform X11
clathrin coat assembly protein AP180 isoform X9
clathrin coat assembly protein AP180 isoform X7
clathrin coat assembly protein AP180 isoform X12
clathrin coat assembly protein AP180 isoform X10
clathrin coat assembly protein AP180 isoform X6
clathrin coat assembly protein AP180 isoform X5
clathrin coat assembly protein AP180 isoform X2
clathrin coat assembly protein AP180 isoform X4
clathrin coat assembly protein AP180 isoform X8
clathrin coat assembly protein AP180 isoform X3
clathrin coat assembly protein AP180 isoform X1
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 17% coverage of the annotated genomic feature by RNAseq alignments
SOGA family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SOGA family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SOGA family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein KIAA0408 homolog
ethylmalonyl-CoA decarboxylase 1, transcript variant X8
ethylmalonyl-CoA decarboxylase 1, transcript variant X2
ethylmalonyl-CoA decarboxylase 1, transcript variant X1
ethylmalonyl-CoA decarboxylase 1, transcript variant X5
ethylmalonyl-CoA decarboxylase 1, transcript variant X7
ethylmalonyl-CoA decarboxylase isoform X1
ethylmalonyl-CoA decarboxylase isoform X3
ethylmalonyl-CoA decarboxylase 1, transcript variant X6
ethylmalonyl-CoA decarboxylase 1, transcript variant X3
ethylmalonyl-CoA decarboxylase 1, transcript variant X4
ethylmalonyl-CoA decarboxylase isoform X2
ring finger protein 146, transcript variant X2
ring finger protein 146, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
tRNA methyltransferase 11 homolog, transcript variant X1
tRNA methyltransferase 11 homolog, transcript variant X3
tRNA methyltransferase 11 homolog, transcript variant X2
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X1
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X2
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X3
histidine triad nucleotide binding protein 3
histidine triad nucleotide-binding protein 3
nuclear receptor coactivator 7, transcript variant X4
nuclear receptor coactivator 7, transcript variant X1
nuclear receptor coactivator 7, transcript variant X5
nuclear receptor coactivator 7, transcript variant X2
nuclear receptor coactivator 7, transcript variant X6
nuclear receptor coactivator 7, transcript variant X3
nuclear receptor coactivator 7, transcript variant X7
nuclear receptor coactivator 7 isoform X2
nuclear receptor coactivator 7 isoform X1
nuclear receptor coactivator 7 isoform X3
nuclear receptor coactivator 7 isoform X4
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
hes related family bHLH transcription factor with YRPW motif 2
hairy/enhancer-of-split related with YRPW motif protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122685585, transcript variant X2
uncharacterized LOC122685585, transcript variant X3
uncharacterized LOC122685585, transcript variant X1
uncharacterized LOC122685455, transcript variant X2
uncharacterized LOC122685455, transcript variant X1
uncharacterized LOC122685455, transcript variant X3
uncharacterized LOC122685455, transcript variant X6
uncharacterized LOC122685455, transcript variant X4
uncharacterized LOC122685455, transcript variant X5
probable E3 ubiquitin-protein ligase RNF217
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium/potassium transporting ATPase interacting 2, transcript variant X2
sodium/potassium transporting ATPase interacting 2, transcript variant X1
sodium/potassium transporting ATPase interacting 2, transcript variant X4
sodium/potassium transporting ATPase interacting 2, transcript variant X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 isoform X1
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 isoform X2
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC122685289, transcript variant X12
uncharacterized LOC122685289, transcript variant X5
uncharacterized LOC122685289, transcript variant X7
uncharacterized LOC122685289, transcript variant X9
uncharacterized LOC122685289, transcript variant X3
uncharacterized LOC122685289, transcript variant X8
uncharacterized LOC122685289, transcript variant X2
uncharacterized LOC122685289, transcript variant X1
uncharacterized LOC122685289, transcript variant X6
uncharacterized LOC122685289, transcript variant X4
uncharacterized LOC122685289, transcript variant X11
uncharacterized LOC122685289, transcript variant X13
uncharacterized LOC122685289, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
sphingomyelin phosphodiesterase acid like 3A, transcript variant X5
sphingomyelin phosphodiesterase acid like 3A, transcript variant X4
sphingomyelin phosphodiesterase acid like 3A, transcript variant X2
sphingomyelin phosphodiesterase acid like 3A, transcript variant X1
sphingomyelin phosphodiesterase acid like 3A, transcript variant X3
sphingomyelin phosphodiesterase acid like 3A, transcript variant X6
acid sphingomyelinase-like phosphodiesterase 3a isoform X2
acid sphingomyelinase-like phosphodiesterase 3a isoform X1
acid sphingomyelinase-like phosphodiesterase 3a isoform X3
cAMP-dependent protein kinase inhibitor beta, transcript variant X3
cAMP-dependent protein kinase inhibitor beta, transcript variant X2
cAMP-dependent protein kinase inhibitor beta, transcript variant X4
cAMP-dependent protein kinase inhibitor beta, transcript variant X1
cAMP-dependent protein kinase inhibitor beta, transcript variant X5
cAMP-dependent protein kinase inhibitor beta
heat shock transcription factor 2, transcript variant X3
heat shock transcription factor 2, transcript variant X2
heat shock transcription factor 2, transcript variant X1
uncharacterized LOC122685268, transcript variant X1
uncharacterized LOC122685268, transcript variant X2
uncharacterized LOC122685263, transcript variant X2
uncharacterized LOC122685263, transcript variant X3
uncharacterized LOC122685263, transcript variant X1
uncharacterized LOC122685263, transcript variant X4
uncharacterized LOC122685264, transcript variant X2
uncharacterized LOC122685264, transcript variant X1
uncharacterized LOC122685517, transcript variant X2
uncharacterized LOC122685517, transcript variant X1
TBC1 domain family member 32, transcript variant X1
TBC1 domain family member 32, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TBC1 domain family member 32, transcript variant X2
histidine triad nucleotide-binding protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
TBC1 domain family member 32, transcript variant X3
TBC1 domain family member 32, transcript variant X6
TBC1 domain family member 32, transcript variant X5
TBC1 domain family member 32, transcript variant X4
glycerol-3-phosphate dehydrogenase 1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA
family with sequence similarity 184 member A, transcript variant X3
family with sequence similarity 184 member A, transcript variant X4
family with sequence similarity 184 member A, transcript variant X1
family with sequence similarity 184 member A, transcript variant X2
family with sequence similarity 184 member A, transcript variant X5
family with sequence similarity 184 member A, transcript variant X6
family with sequence similarity 184 member A, transcript variant X7
family with sequence similarity 184 member A, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 ESTs, 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X20
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X5
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X4
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X6
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X8
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X9
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X7
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X10
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X11
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X17
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X18
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X19
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X3
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X2
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 3 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 3 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X1
anti-silencing function 1A histone chaperone
centrosomal protein 85 like, transcript variant X2
centrosomal protein 85 like, transcript variant X1
centrosomal protein of 85 kDa-like isoform X1
centrosomal protein of 85 kDa-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00492
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122685345, transcript variant X1
uncharacterized LOC122685345, transcript variant X2
NUS1 dehydrodolichyl diphosphate synthase subunit
dehydrodolichyl diphosphate synthase complex subunit NUS1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
golgi associated PDZ and coiled-coil motif containing, transcript variant X1
golgi associated PDZ and coiled-coil motif containing, transcript variant X2
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X1
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X2
discoidin, CUB and LCCL domain containing 1, transcript variant X1
discoidin, CUB and LCCL domain-containing protein 1 isoform X1
discoidin, CUB and LCCL domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
discoidin, CUB and LCCL domain-containing protein 1 isoform X2
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X5
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X3
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X4
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ROS proto-oncogene 1, receptor tyrosine kinase, transcript variant X8
proto-oncogene tyrosine-protein kinase ROS isoform X1
proto-oncogene tyrosine-protein kinase ROS isoform X7
proto-oncogene tyrosine-protein kinase ROS isoform X5
proto-oncogene tyrosine-protein kinase ROS isoform X3
proto-oncogene tyrosine-protein kinase ROS isoform X2
proto-oncogene tyrosine-protein kinase ROS isoform X4
proto-oncogene tyrosine-protein kinase ROS isoform X6
proto-oncogene tyrosine-protein kinase ROS isoform X8
uncharacterized LOC122685545, transcript variant X1
uncharacterized LOC122685545, transcript variant X3
uncharacterized LOC122685545, transcript variant X2
vestigial like family member 2, transcript variant X1
vestigial like family member 2, transcript variant X4
vestigial like family member 2, transcript variant X3
vestigial like family member 2, transcript variant X2
vestigial like family member 2, transcript variant X5
transcription cofactor vestigial-like protein 2 isoform X2
transcription cofactor vestigial-like protein 2 isoform X1
transcription cofactor vestigial-like protein 2 isoform X3
G protein-coupled receptor class C group 6 member A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 7 bases in 4 codons; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: G-protein coupled receptor family C group 6 member A
family with sequence similarity 162 member B
zinc finger containing ubiquitin peptidase 1, transcript variant X1
zinc finger containing ubiquitin peptidase 1, transcript variant X5
zinc finger containing ubiquitin peptidase 1, transcript variant X2
zinc finger containing ubiquitin peptidase 1, transcript variant X3
zinc finger containing ubiquitin peptidase 1, transcript variant X4
zinc finger-containing ubiquitin peptidase 1 isoform X1
zinc finger-containing ubiquitin peptidase 1 isoform X3
zinc finger-containing ubiquitin peptidase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
amine sulfotransferase-like, transcript variant X2
amine sulfotransferase-like, transcript variant X1
RWD domain containing 1, transcript variant X1
RWD domain containing 1, transcript variant X2
RWD domain-containing protein 1 isoform X1
RWD domain-containing protein 1 isoform X2
trafficking protein particle complex subunit 3L, transcript variant X1
trafficking protein particle complex subunit 3L, transcript variant X3
trafficking protein particle complex subunit 3L, transcript variant X2
calcium homeostasis modulator family member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
trafficking protein particle complex subunit 3-like protein
calcium homeostasis modulator family member 5, transcript variant X2
calcium homeostasis modulator family member 5, transcript variant X1
calcium homeostasis modulator protein 5 isoform X2
calcium homeostasis modulator protein 5 isoform X1
calcium homeostasis modulator family member 6
dermatan sulfate epimerase, transcript variant X2
dermatan sulfate epimerase, transcript variant X3
dermatan sulfate epimerase, transcript variant X1
dermatan sulfate epimerase, transcript variant X4
testis-specific Y-encoded-like protein 1
testis-specific Y-encoded-like protein 4
5'-nucleotidase domain containing 1, transcript variant X2
5'-nucleotidase domain containing 1, transcript variant X1
5'-nucleotidase domain-containing protein 1 isoform X2
5'-nucleotidase domain-containing protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X4
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X1
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X5
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X6
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X3
heparan sulfate-glucosamine 3-sulfotransferase 5, transcript variant X2
heparan sulfate glucosamine 3-O-sulfotransferase 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
myristoylated alanine rich protein kinase C substrate
myristoylated alanine-rich C-kinase substrate
uncharacterized LOC122685284, transcript variant X2
uncharacterized LOC122685284, transcript variant X1
uncharacterized LOC122685603, transcript variant X1
uncharacterized LOC122685603, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ret finger protein-like 4B
laminin subunit alpha 4, transcript variant X1
laminin subunit alpha 4, transcript variant X3
laminin subunit alpha 4, transcript variant X2
family with sequence similarity 229 member B, transcript variant X1
family with sequence similarity 229 member B, transcript variant X10
family with sequence similarity 229 member B, transcript variant X7
family with sequence similarity 229 member B, transcript variant X8
family with sequence similarity 229 member B, transcript variant X2
family with sequence similarity 229 member B, transcript variant X11
family with sequence similarity 229 member B, transcript variant X14
family with sequence similarity 229 member B, transcript variant X4
family with sequence similarity 229 member B, transcript variant X6
family with sequence similarity 229 member B, transcript variant X3
family with sequence similarity 229 member B, transcript variant X13
family with sequence similarity 229 member B, transcript variant X5
family with sequence similarity 229 member B, transcript variant X9
family with sequence similarity 229 member B, transcript variant X12
family with sequence similarity 229 member B, transcript variant X15
tubulin epsilon 1, transcript variant X1
tubulin epsilon 1, transcript variant X2
tubulin epsilon 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cellular communication network factor 6, transcript variant X1
cellular communication network factor 6 isoform X1
cellular communication network factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cellular communication network factor 6 isoform X2
uncharacterized LOC122685604, transcript variant X1
uncharacterized LOC122685604, transcript variant X3
uncharacterized LOC122685604, transcript variant X4
uncharacterized LOC122685604, transcript variant X2
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X4
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X2
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X1
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X3
TRAF3 interacting protein 2, transcript variant X1
TRAF3 interacting protein 2, transcript variant X2
uncharacterized LOC122685537, transcript variant X3
uncharacterized LOC122685537, transcript variant X1
uncharacterized LOC122685537, transcript variant X2
REV3 like, DNA directed polymerase zeta catalytic subunit, transcript variant X1
REV3 like, DNA directed polymerase zeta catalytic subunit, transcript variant X2
DNA polymerase zeta catalytic subunit isoform X1
DNA polymerase zeta catalytic subunit isoform X2
REV3 like, DNA directed polymerase zeta catalytic subunit, transcript variant X3
DNA polymerase zeta catalytic subunit isoform X3
major facilitator superfamily domain containing 4B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sodium-dependent glucose transporter 1
solute carrier family 16 member 10, transcript variant X2
solute carrier family 16 member 10, transcript variant X1
monocarboxylate transporter 10 isoform X2
monocarboxylate transporter 10 isoform X1
general transcription factor IIIC subunit 6
general transcription factor 3C polypeptide 6
cyclin dependent kinase 19, transcript variant X3
S-adenosylmethionine decarboxylase proenzyme
cyclin dependent kinase 19, transcript variant X1
cyclin dependent kinase 19, transcript variant X2
uncharacterized LOC122685374, transcript variant X2
uncharacterized LOC122685374, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
D-aspartate oxidase, transcript variant X7
D-aspartate oxidase, transcript variant X4
D-aspartate oxidase, transcript variant X11
D-aspartate oxidase, transcript variant X6
D-aspartate oxidase, transcript variant X1
D-aspartate oxidase, transcript variant X3
D-aspartate oxidase, transcript variant X8
D-aspartate oxidase, transcript variant X9
D-aspartate oxidase, transcript variant X5
D-aspartate oxidase, transcript variant X10
D-aspartate oxidase, transcript variant X2
WASP family member 1, transcript variant X1
WASP family member 1, transcript variant X2
WASP family member 1, transcript variant X4
WASP family member 1, transcript variant X3
wiskott-Aldrich syndrome protein family member 1 isoform X1
wiskott-Aldrich syndrome protein family member 1 isoform X2
wiskott-Aldrich syndrome protein family member 1 isoform X3
wiskott-Aldrich syndrome protein family member 1 isoform X4
zinc finger and BTB domain containing 24, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
zinc finger and BTB domain containing 24, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
zinc finger and BTB domain containing 24, transcript variant X6
zinc finger and BTB domain containing 24, transcript variant X2
zinc finger and BTB domain containing 24, transcript variant X1
zinc finger and BTB domain containing 24, transcript variant X4
zinc finger and BTB domain containing 24, transcript variant X3
zinc finger and BTB domain-containing protein 24 isoform X1
zinc finger and BTB domain-containing protein 24 isoform X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
peptidylprolyl isomerase like 6, transcript variant X1
peptidylprolyl isomerase like 6, transcript variant X2
peptidylprolyl isomerase like 6, transcript variant X4
peptidylprolyl isomerase like 6, transcript variant X6
peptidylprolyl isomerase like 6, transcript variant X5
peptidylprolyl isomerase like 6, transcript variant X3
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X1
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X2
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X4
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X6
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X5
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
centrosomal protein 57 like 1, transcript variant X4
centrosomal protein 57 like 1, transcript variant X3
centrosomal protein 57 like 1, transcript variant X2
centrosomal protein 57 like 1, transcript variant X5
centrosomal protein 57 like 1, transcript variant X6
centrosomal protein 57 like 1, transcript variant X1
armadillo repeat containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
armadillo repeat containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
armadillo repeat containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
armadillo repeat-containing protein 2 isoform X2
armadillo repeat-containing protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 8 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nuclear receptor subfamily 2 group E member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear receptor subfamily 2 group E member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 7 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear receptor subfamily 2 group E member 1 isoform X1
nuclear receptor subfamily 2 group E member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
osteoclastogenesis associated transmembrane protein 1
osteopetrosis-associated transmembrane protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SEC63 homolog, protein translocation regulator
Scm polycomb group protein like 4, transcript variant X5
Scm polycomb group protein like 4, transcript variant X3
Scm polycomb group protein like 4, transcript variant X1
Scm polycomb group protein like 4, transcript variant X6
Scm polycomb group protein like 4, transcript variant X4
Scm polycomb group protein like 4, transcript variant X2
sex comb on midleg-like protein 4 isoform X1
sex comb on midleg-like protein 4 isoform X3
sex comb on midleg-like protein 4 isoform X2
Scm polycomb group protein like 4, transcript variant X7
sex comb on midleg-like protein 4 isoform X4
sine oculis binding protein homolog, transcript variant X2
sine oculis binding protein homolog, transcript variant X1
sine oculis binding protein homolog, transcript variant X3
sine oculis-binding protein homolog isoform X2
sine oculis-binding protein homolog isoform X1
sine oculis-binding protein homolog isoform X3
decaprenyl diphosphate synthase subunit 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
decaprenyl diphosphate synthase subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
decaprenyl diphosphate synthase subunit 2, transcript variant X4
decaprenyl diphosphate synthase subunit 2, transcript variant X3
decaprenyl diphosphate synthase subunit 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
decaprenyl diphosphate synthase subunit 2, transcript variant X5
decaprenyl diphosphate synthase subunit 2, transcript variant X6
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X7
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X1
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X2
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X3
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X5
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X6
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 ESTs, 12 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
BEN domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BEN domain containing 3, transcript variant X1
BEN domain containing 3, transcript variant X2
BEN domain containing 3, transcript variant X4
BEN domain-containing protein 3 isoform X1
BEN domain-containing protein 3 isoform X2
BEN domain containing 3, transcript variant X5
BEN domain containing 3, transcript variant X6
BEN domain-containing protein 3 isoform X3
mitochondrial transcription rescue factor 1, transcript variant X4
mitochondrial transcription rescue factor 1, transcript variant X2
mitochondrial transcription rescue factor 1, transcript variant X1
mitochondrial transcription rescue factor 1, transcript variant X3
mitochondrial transcription rescue factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00191
glutaminyl-tRNA amidotransferase subunit QRSL1, transcript variant X2
glutaminyl-tRNA amidotransferase subunit QRSL1, transcript variant X1
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial isoform X2
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial isoform X1
reticulon-4-interacting protein 1, mitochondrial
crystallin beta-gamma domain containing 1, transcript variant X1
crystallin beta-gamma domain containing 1, transcript variant X2
beta/gamma crystallin domain-containing protein 1 isoform X1
beta/gamma crystallin domain-containing protein 1 isoform X2
autophagy related 5, transcript variant X4
autophagy related 5, transcript variant X2
autophagy related 5, transcript variant X1
autophagy related 5, transcript variant X3
autophagy related 5, transcript variant X5
PR domain zinc finger protein 1 isoform X1
PR domain zinc finger protein 1 isoform X2
PR domain zinc finger protein 1 isoform X3
PR domain zinc finger protein 1 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00554
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
uncharacterized LOC122685414, transcript variant X1
uncharacterized LOC122685414, transcript variant X2
blood vessel epicardial substance, transcript variant X2
blood vessel epicardial substance, transcript variant X1
blood vessel epicardial substance isoform X1
blood vessel epicardial substance, transcript variant X3
blood vessel epicardial substance isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, transcript variant X1
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, transcript variant X2
E3 ubiquitin-protein ligase HACE1 isoform X1
E3 ubiquitin-protein ligase HACE1 isoform X2
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, transcript variant X4
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, transcript variant X5
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1, transcript variant X3
E3 ubiquitin-protein ligase HACE1 isoform X3
E3 ubiquitin-protein ligase HACE1 isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
LOW QUALITY PROTEIN: probable tubulin polyglutamylase TTLL1
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutamate ionotropic receptor kainate type subunit 2, transcript variant X4
glutamate ionotropic receptor kainate type subunit 2, transcript variant X5
glutamate ionotropic receptor kainate type subunit 2, transcript variant X9
glutamate ionotropic receptor kainate type subunit 2, transcript variant X1
glutamate ionotropic receptor kainate type subunit 2, transcript variant X3
glutamate ionotropic receptor kainate type subunit 2, transcript variant X2
glutamate ionotropic receptor kainate type subunit 2, transcript variant X6
glutamate ionotropic receptor kainate type subunit 2, transcript variant X12
glutamate receptor ionotropic, kainate 2 isoform X3
glutamate receptor ionotropic, kainate 2 isoform X1
glutamate receptor ionotropic, kainate 2 isoform X5
glutamate ionotropic receptor kainate type subunit 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor kainate type subunit 2, transcript variant X8
glutamate receptor ionotropic, kainate 2 isoform X2
glutamate ionotropic receptor kainate type subunit 2, transcript variant X10
glutamate receptor ionotropic, kainate 2 isoform X4
glutamate ionotropic receptor kainate type subunit 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, kainate 2 isoform X6
glutamate ionotropic receptor kainate type subunit 2, transcript variant X14
glutamate receptor ionotropic, kainate 2 isoform X7
activating signal cointegrator 1 complex subunit 3, transcript variant X1
activating signal cointegrator 1 complex subunit 3, transcript variant X2
activating signal cointegrator 1 complex subunit 3
SIM bHLH transcription factor 1, transcript variant X1
SIM bHLH transcription factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments
melanin concentrating hormone receptor 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: melanin-concentrating hormone receptor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
cytochrome c oxidase subunit 7A2, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 9 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
thiosulfate sulfurtransferase like domain containing 3
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3
ubiquitin specific peptidase 45, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 3 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin specific peptidase 45, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ubiquitin specific peptidase 45, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin specific peptidase 45, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 45 isoform X1
ubiquitin carboxyl-terminal hydrolase 45 isoform X2
ubiquitin carboxyl-terminal hydrolase 45 isoform X4
ubiquitin carboxyl-terminal hydrolase 45 isoform X5
ubiquitin specific peptidase 45, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 45 isoform X3
PNN interacting serine and arginine rich protein, transcript variant X7
PNN interacting serine and arginine rich protein, transcript variant X8
PNN interacting serine and arginine rich protein, transcript variant X9
PNN interacting serine and arginine rich protein, transcript variant X1
PNN interacting serine and arginine rich protein, transcript variant X6
PNN interacting serine and arginine rich protein, transcript variant X2
PNN interacting serine and arginine rich protein, transcript variant X3
PNN interacting serine and arginine rich protein, transcript variant X5
PNN interacting serine and arginine rich protein, transcript variant X4
arginine/serine-rich protein PNISR isoform X1
arginine/serine-rich protein PNISR isoform X2
arginine/serine-rich protein PNISR isoform X3
arginine/serine-rich protein PNISR isoform X4
ubiquinone biosynthesis O-methyltransferase, mitochondrial
failed axon connections homolog, metaxin like GST domain containing, transcript variant X4
failed axon connections homolog, metaxin like GST domain containing, transcript variant X2
failed axon connections homolog, metaxin like GST domain containing, transcript variant X3
failed axon connections homolog, metaxin like GST domain containing, transcript variant X1
failed axon connections homolog isoform X1
failed axon connections homolog isoform X2
failed axon connections homolog isoform X3
F-box and leucine rich repeat protein 4, transcript variant X1
F-box and leucine rich repeat protein 4, transcript variant X2
POU domain, class 3, transcription factor 2
MMS22 like, DNA repair protein, transcript variant X1
MMS22 like, DNA repair protein, transcript variant X2
MMS22 like, DNA repair protein, transcript variant X3
MMS22 like, DNA repair protein, transcript variant X4
MMS22 like, DNA repair protein, transcript variant X5
kelch like family member 32, transcript variant X5
kelch like family member 32, transcript variant X2
kelch like family member 32, transcript variant X4
kelch like family member 32, transcript variant X3
kelch like family member 32, transcript variant X8
kelch like family member 32, transcript variant X1
kelch like family member 32, transcript variant X6
kelch like family member 32, transcript variant X7
kelch like family member 32, transcript variant X10
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
kelch like family member 32, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase complex assembly factor 4
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4
G protein-coupled receptor 63, transcript variant X1
G protein-coupled receptor 63, transcript variant X3
G protein-coupled receptor 63, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
fucosyltransferase 9, transcript variant X1
fucosyltransferase 9, transcript variant X2
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
uncharacterized LOC122685591, transcript variant X2
uncharacterized LOC122685591, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
chromodomain-helicase-DNA-binding protein 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
LOW QUALITY PROTEIN: chromodomain-helicase-DNA-binding protein 4-like
uncharacterized LOC122685513, transcript variant X1
uncharacterized LOC122685513, transcript variant X2
mitogen-activated protein kinase kinase kinase 7, transcript variant X1
mitogen-activated protein kinase kinase kinase 7, transcript variant X2
mitogen-activated protein kinase kinase kinase 7, transcript variant X3
mitogen-activated protein kinase kinase kinase 7 isoform X1
mitogen-activated protein kinase kinase kinase 7 isoform X2
mitogen-activated protein kinase kinase kinase 7 isoform X3
mitogen-activated protein kinase kinase kinase 7, transcript variant X4
mitogen-activated protein kinase kinase kinase 7 isoform X4
BTB domain and CNC homolog 2, transcript variant X1
BTB domain and CNC homolog 2, transcript variant X2
transcription regulator protein BACH2 isoform X2
transcription regulator protein BACH2 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gap junction alpha-10 protein
caspase 8 associated protein 2, transcript variant X1
caspase 8 associated protein 2, transcript variant X2
caspase 8 associated protein 2, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
midasin AAA ATPase 1, transcript variant X1
midasin AAA ATPase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 6, transcript variant X3
ankyrin repeat domain 6, transcript variant X8
ankyrin repeat domain 6, transcript variant X9
ankyrin repeat domain 6, transcript variant X6
ankyrin repeat domain 6, transcript variant X4
ankyrin repeat domain 6, transcript variant X5
ankyrin repeat domain 6, transcript variant X7
ankyrin repeat domain 6, transcript variant X2
ankyrin repeat domain 6, transcript variant X1
ankyrin repeat domain-containing protein 6 isoform X6
ankyrin repeat domain-containing protein 6 isoform X7
ankyrin repeat domain-containing protein 6 isoform X4
ankyrin repeat domain-containing protein 6 isoform X3
ankyrin repeat domain-containing protein 6 isoform X5
ankyrin repeat domain-containing protein 6 isoform X2
ankyrin repeat domain-containing protein 6 isoform X1
gamma-aminobutyric acid type A receptor subunit rho2
gamma-aminobutyric acid receptor subunit rho-2
gamma-aminobutyric acid type A receptor subunit rho1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit rho-1 isoform X1
gamma-aminobutyric acid type A receptor subunit rho1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit rho-1 isoform X2
peptidase M20 domain containing 2, transcript variant X1
peptidase M20 domain containing 2, transcript variant X2
peptidase M20 domain-containing protein 2 isoform X2
peptidase M20 domain-containing protein 2 isoform X1
serine and arginine rich splicing factor 12, transcript variant X1
serine and arginine rich splicing factor 12, transcript variant X2
serine and arginine rich splicing factor 12, transcript variant X3
serine/arginine-rich splicing factor 12 isoform X1
serine and arginine rich splicing factor 12, transcript variant X4
serine/arginine-rich splicing factor 12 isoform X2
proline rich nuclear receptor coactivator 1
proline-rich nuclear receptor coactivator 1
RNA guanylyltransferase and 5'-phosphatase, transcript variant X1
RNA guanylyltransferase and 5'-phosphatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
cannabinoid receptor 1, transcript variant X4
cannabinoid receptor 1, transcript variant X5
cannabinoid receptor 1, transcript variant X2
cannabinoid receptor 1, transcript variant X1
cannabinoid receptor 1, transcript variant X3
sperm acrosome membrane-associated protein 1
origin recognition complex subunit 3, transcript variant X5
origin recognition complex subunit 3, transcript variant X2
origin recognition complex subunit 3, transcript variant X1
origin recognition complex subunit 3, transcript variant X3
origin recognition complex subunit 3, transcript variant X4
origin recognition complex subunit 3, transcript variant X7
origin recognition complex subunit 3, transcript variant X6
origin recognition complex subunit 3 isoform X5
origin recognition complex subunit 3 isoform X2
origin recognition complex subunit 3 isoform X1
origin recognition complex subunit 3 isoform X4
origin recognition complex subunit 3 isoform X6
origin recognition complex subunit 3 isoform X3
arginyl-tRNA synthetase 2, mitochondrial, transcript variant X1
probable arginine--tRNA ligase, mitochondrial isoform X1
arginyl-tRNA synthetase 2, mitochondrial, transcript variant X3
arginyl-tRNA synthetase 2, mitochondrial, transcript variant X2
probable arginine--tRNA ligase, mitochondrial isoform X2
solute carrier family 35 member A1, transcript variant X3
solute carrier family 35 member A1, transcript variant X1
solute carrier family 35 member A1, transcript variant X2
cilia and flagella associated protein 206, transcript variant X4
cilia and flagella associated protein 206, transcript variant X2
cilia and flagella associated protein 206, transcript variant X1
cilia and flagella associated protein 206, transcript variant X3
cilia and flagella associated protein 206, transcript variant X5
cilia- and flagella-associated protein 206 isoform X3
cilia- and flagella-associated protein 206 isoform X2
cilia- and flagella-associated protein 206 isoform X1
cilia- and flagella-associated protein 206 isoform X4
chromosome 28 C6orf163 homolog, transcript variant X2
chromosome 28 C6orf163 homolog, transcript variant X1
uncharacterized protein C6orf163 homolog isoform X2
uncharacterized protein C6orf163 homolog isoform X1
small integral membrane protein 8, transcript variant X2
small integral membrane protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 292, transcript variant X1
zinc finger protein 292, transcript variant X2
zinc finger protein 292, transcript variant X3
glycoprotein hormones, alpha polypeptide, transcript variant X1
glycoprotein hormones alpha chain isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
glycoprotein hormones, alpha polypeptide, transcript variant X2
glycoprotein hormones alpha chain isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00099
uncharacterized LOC122685423, transcript variant X2
uncharacterized LOC122685423, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00278
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X4
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X6
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X2
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X1
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X3
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X5
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X7
heterogeneous nuclear ribonucleoprotein Q isoform X2
heterogeneous nuclear ribonucleoprotein Q isoform X3
heterogeneous nuclear ribonucleoprotein Q isoform X1
heterogeneous nuclear ribonucleoprotein Q isoform X4
heterogeneous nuclear ribonucleoprotein Q isoform X6
heterogeneous nuclear ribonucleoprotein Q isoform X5
sorting nexin 14, transcript variant X10
5'-nucleotidase ecto, transcript variant X1
5'-nucleotidase ecto, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
POU domain, class 5, transcription factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments